Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

Clicks: 215
ID: 111239
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
AbstractBackground. Severely immunocompromised human immunodeficiency virus (HIV)–infected individuals have high mortality shortly after starting antiretrovira
Reference Key
abraham2018clinicallate Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Siika, Abraham;McCabe, Leanne;Bwakura-Dangarembizi, Mutsa;Kityo, Cissy;Mallewa, Jane;Berkley, Jay;Maitland, Kath;Griffiths, Anna;Baleeta, Keith;Mudzingwa, Shepherd;Abach, James;Nathoo, Kusum;Thomason, Margaret J;Prendergast, Andrew J;Walker, Ann Sarah;Gibb, Diana M;REALITY Trial Team;Mugyenyi, P;Kityo, C;Musiime, V;Wavamunno, P;Nambi, E;Ocitti, P;Ndigendawani, M;Kemigisa, M;Acen, J;Olebo, D;Mpamize, G;Amone, A;Okweny, D;Mbonye, A;Nambaziira, F;Rweyora, A;Kangah, M;Kabaswahili, V;Abach, J;Abongomera, G;Omongin, J;Aciro, I;Philliam, A;Arach, B;Ocung, E;Amone, G;Miles, P;Adong, C;Tumsuiime, C;Kidega, P;Otto, B;Apio, F;Baleeta, K;Mukuye, A;Abwola, M;Ssennono, F;Baliruno, D;Tuhirwe, S;Namisi, R;Kigongo, F;Kikyonkyo, D;Mushahara, F;Okweny, D;Tusiime, J;Musiime, A;Nankya, A;Atwongyeire, D;Sirikye, S;Mula, S;Noowe, N;Lugemwa, A;Kasozi, M;Mwebe, S;Atwine, L;Senkindu, T;Natuhurira, T;Katemba, C;Ninsiima, E;Acaku, M;Kyomuhangi, J;Ankunda, R;Tukwasibwe, D;Ayesiga, L;Hakim, J;Nathoo, K;Bwakura-Dangarembizi, M;Reid, A;Chidziva, E;Mhute, T;Tinago, GC;Bhiri, J;Mudzingwa, S;Phiri, M;Steamer, J;Nhema, R;Warambwa, C;Musoro, G;Mutsai, S;Nemasango, B;Moyo, C;Chitongo, S;Rashirai, K;Vhembo, S;Mlambo, B;Nkomani, S;Ndemera, B;Willard, M;Berejena, C;Musodza, Y;Matiza, P;Mudenge, B;Guti, V;Etyang, A;Agutu, C;Berkley, J;Maitland, K;Njuguna, P;Mwaringa, S;Etyang, T;Awuondo, K;Wale, S;Shangala, J;Kithunga, J;Mwarumba, S;Said Maitha, S;Mutai, R;Lozi Lewa, M;Mwambingu, G;Mwanzu, A;Kalama, C;Latham, H;Shikuku, J;Fondo, A;Njogu, A;Khadenge, C;Mwakisha, B;Siika, A;Wools-Kaloustian, K;Nyandiko, W;Cheruiyot, P;Sudoi, A;Wachira, S;Meli, B;Karoney, M;Nzioka, A;Tanui, M;Mokaya, M;Ekiru, W;Mboya, C;Mwimali, D;Mengich, C;Choge, J;Injera, W;Njenga, K;Cherutich, S;Anyango Orido, M;Omondi Lwande, G;Rutto, P;Mudogo, A;Kutto, I;Shali, A;Jaika, L;Jerotich, H;Pierre, M;Mallewa, J;Kaunda, S;Van Oosterhout, J;O’Hare, B;Heydermann, R;Gonzalez, C;Dzabala, N;Kelly, C;Denis, B;Selemani, G;Nyondo Mipando, L;Chirwa, E;Banda, P;Mvula, L;Msuku, H;Ziwoya, M;Manda, Y;Nicholas, S;Masesa, C;Mwalukomo, T;Makhaza, L;Sheha, I;Bwanali, J;Limbuni, M;Gibb, D;Thomason, M;Walker, AS;Pett, S;Szubert, A;Griffiths, A;Wilkes, H;Rajapakse, C;Spyer, M;Prendergast, A;Klein, N;Van Looy, N;Little, E;Fairbrother, K;Cowan, F;Seeley, J;Bernays, S;Kawuma, R;Mupambireyi, Z;Kyomuhendo, F;Nakalanzi, S;Peshu, J;Ndaa, S;Chabuka, J;Mkandawire, N;Matandika, L;Kapuya, C;Weller, I;Malianga, E;Mwansambo, C;Miiro, F;Elyanu, P;Bukusi, E;Katabira, E;Mugurungi, O;Gibb, D;Hakim, J;Etyang, A;Mugyenyi, P;Mallewa, J;Peto, T;Musoke, P;Matenga, J;Phiri, S;Lyall, H;Johnston, V;Fitzgerald, F;Post, F;Ssali, F;Prendergast, A;Arenas-Pinto, A;Turkova, A;Bamford, A;
Journal clinical infectious diseases
Year 2018
DOI
DOI not found
URL
https://academic.oup.com/cid/article/66/suppl_2/S140/4918991?searchresult=1#supplementary-data
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male age factors adolescent Child preschool risk factors Randomized Controlled Trial phenotype immunocompromised host anti-hiv agents / therapeutic use hiv infections / mortality* africa south of the sahara / epidemiology risk assessment antiretroviral therapy hiv infections / drug therapy* hiv pmid:29514235 pmc5850547 doi:10.1093/cid/cix1142 abraham siika leanne mccabe reality trial team aids-related opportunistic infections / drug therapy* aids-related opportunistic infections / mortality* highly active / statistics & numerical data* cd4 lymphocyte count / statistics & numerical data

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.